TAIHO ONCOLOGY Logo (WIPO, 25.03.2014)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke TAIHO ONCOLOGY wurde als Bildmarke am 25.03.2014 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Briefe, die eine besondere Form des Schreibens darstellen #Farben #Rot, rosa, orange
| Markenform | Bildmarke |
| Aktenzeichen | 1220422 |
| Registernummer | 5654402 |
| Länder | 
|
| Basismarke |
Nr. 5654402,
07. März 2014
|
| Anmeldedatum | 25. März 2014 |
| Ablaufdatum | 25. März 2024 |
Markeninhaber
1-27 Kandanishiki-cho,
Chiyoda-ku
JP
Chiyoda-ku
JP
Markenvertreter
c/o Saegusa & Partners, Tokyo Office,
TORANOMON MITSUI Building 9F,
JP
Waren und Dienstleistungen
05
Anti-cancer preparations and substances; anti-ulcerogenic
preparations and substances; pharmaceutical preparations and
substances for the treatment of immunological diseases;
pharmaceutical preparations and substances for the treatment
of urinary diseases; therapeutic preparations and substances
for pain; antiemetic preparations and substances; diagnostic
preparations and substances; drugs for genetic testing;
pharmaceutical preparations; dietary supplements for humans;
dietetic foods adapted for medical purposes
44
Diagnostic services of cancer, tumor, ulceration,
immunological diseases, urinary diseases, nausea, vomiting
and pain; providing information relating to the treatment or
prevention of cancer, tumor, ulceration, immunological
diseases, urinary diseases, nausea, vomiting and pain;
consultation services relating to the treatment and
diagnosis of cancer, tumor, ulceration, immunological
diseases, urinary diseases, nausea, vomiting and pain;
medical counseling services relating to the treatment of
cancer, tumor, ulceration, immunological diseases, urinary
diseases, nausea, vomiting and pain; medical analysis
services and genetic testing for the diagnosis and prognosis
of the expected progression of cancer, tumor, ulceration,
immunological diseases, urinary diseases, nausea, vomiting
and pain; providing medical information relating to
efficacy, side effects, interactions of pharmaceuticals and
medication; collecting and managing clinical data in
relation to clinical trials of pharmaceuticals; medical
services; providing medical information; physical
examination; dentistry; preparation and dispensing of
medications
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 04. Oktober 2022 | 2022/41 Gaz | US | RAW: Total Invalidation |
| 27. Juni 2019 | 2019/28 Gaz | CN | RAW: Rule 18ter(4) all goods and services protected |
| 11. April 2018 | 2018/38 Gaz | VN | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 13. November 2015 | 2015/49 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 05. November 2015 | 2015/45 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 26. Oktober 2015 | 2015/45 Gaz | VN | Ablehnung |
| 23. Oktober 2015 | 2015/44 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 13. Oktober 2015 | 2015/43 Gaz | CN | Ablehnung |
| 25. August 2015 | 2015/35 Gaz | EM | Ablehnung |
| 16. März 2015 | 2015/12 Gaz | KR | Ablehnung |
| 04. März 2015 | 2015/12 Gaz | SG | Ablehnung |
| 13. November 2014 | 2014/46 Gaz | US | Ablehnung |
| 25. März 2014 | 2014/41 Gaz | JP | Eintragung |
ID: 141220422